Literature DB >> 10735631

Functional characterization of two low density lipoprotein receptor gene mutations by fluorescence flow cytometric assessment of receptor activity in stimulated human T-lymphocytes.

B Raungaard1, H K Jensen, J U Brorholt-Petersen, F Heath, O Faergeman.   

Abstract

We report a functional characterization of the W23X and W66G low density lipoprotein (LDL) receptor gene mutations. The authors used two-color fluorescence flow cytometry to measure LDL receptor activity in stimulated T-lymphocytes, prepared from patients heterozygous for the W23X or W66G mutation, and compared the results with measurements of LDL receptor activity in stimulated T-lymphocytes prepared from unrelated healthy control subjects. It was found that the W23X mutation significantly reduced LDL receptor expression and LDL binding and internalization, and that the W66G mutation significantly reduced LDL receptor expression and LDL binding. LDL internalization in patients heterozygous for the W66G mutation was not significantly reduced. The data support the concepts that the W23X mutation prevents production of LDL receptors (class I) and that the W66G mutation produces LDL receptors unable to recycle normally in cells (class V).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735631     DOI: 10.1034/j.1399-0004.2000.570204.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  2 in total

1.  A novel mutation (Cys308Phe) of the LDL receptor gene in families from the South-Eastern part of Poland.

Authors:  Małgorzata Waluś-Miarka; Marek Sanak; Barbara Idzior-Waluś; Przemysław Miarka; Przemysław Witek; Maciej T Małecki; Danuta Czarnecka
Journal:  Mol Biol Rep       Date:  2011-12-13       Impact factor: 2.316

2.  LDL receptor expression on T lymphocytes in old patients with Down syndrome.

Authors:  Massimiliano M Corsi; Alexis E Malavazos; Daniele Passoni; Federico Licastro
Journal:  Immun Ageing       Date:  2005-02-10       Impact factor: 6.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.